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Physical activity (PA) has been hypothesized to be effective to maintaining cognitive function 
and delay cognitive decline in the elderly, but physical fitness (PF) could be a better predictor of 
cognitive function. We aimed to study the association between PA and PF with cognitive function 
and quality of life using cross-sectional data from 6874 participants of the PREDIMED-Plus trial 
(64.9 ± 4.9 years, 48.5% female). PF and PA were measured with a Chair Stand Test, the REGICOR 
and Rapid Assessment Physical Activity questionnaires. Cognitive function was measured with Mini-
mental State Examination, Control Oral Word Association Test, Trail Making Test and Digit Span 
tests; whereas health-related quality of life was assessed with the SF36-HRQL test. Cognitive and 
quality of life scores were compared among PF quartiles and PA levels (low, moderate and high) with 
ANCOVA and with Chair Stand repetitions and energy expenditure from total PA with multivariable 
linear regression adjusted for confounding factors. PF associated with higher scores in phonemic 
and semantic verbal fluency tests and with lower TMT A time. However, PA was not associated with 
the neurocognitive parameters evaluated. Both PF and PA levels were strongly associated with a 
better quality of life. We concluded that PF, but not PA, is associated with a better cognitive function. 
This trial was retrospectively registered at the International Standard Randomized Controlled Trial 
(ISRCTN89898870, https://www.isrctn.com/ISRCTN89898870?q=ISRCTN89898870&filters=&sort=&o
ffset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search) on 07/24/2014.
Aging traditionally involves a decline in executive functions, which in some cases progresses towards cognitive 
impairment. Given that the world’s population is getting older, the prevalence of subjective cognitive decline and 
mild cognitive impairment (MCI) is on the rise1,2. Therefore, the development of strategies to maintain normal 
cognitive function and delay cognitive decline is relevant.
Cardiovascular risk factors like type 2 diabetes (T2DM) or obesity, have been consistently associated with 
cognitive decline and MCI2,3, as well as the progression to dementia4. Thus, it has been postulated that therapeutic 
management of these factors can be useful to maintain cognitive function and even slow down cognitive decline2. 
Therapies based on lifestyle interventions, specifically those designed to prevent cardiovascular disease, could be 
a safe approach to maintain cognitive function and delay aging-associated decline. Although approaches using 
dietary supplements did not report significant benefits5,6, studies with traditional Mediterranean Diet (MedDiet) 
have shown promising results7–10. MedDiet has also been reported to be associated with better self-reported 
quality of life11.
Physical activity (PA) is another modifiable lifestyle factor with potentially large beneficial effects on cognitive 
functioning. It has been postulated that exercise promotes healthy aging and has beneficial effects on cognition in 
the elderly12. Several cross-sectional analyses and interventional studies have found positive associations between 
PA, especially aerobic exercise, and cognitive function in the elderly13–16. These studies strongly suggest that the 
PA association with cognitive function is relevant enough to be taken into consideration when designing lifestyle 
interventions addressed to improve health in the elderly. However, reported associations between PA and cogni-
tive health are often small to moderate, depending on the cognitive domain, and inconsistent across studies15–23. 
PA has also been associated with a better subjective quality of life24,25.
Although there is compelling evidence pointing towards an association between PA and cognitive function, 
the heterogeneity of the findings calls for additional research to unravel those conditions where the effect is 
beneficial. These inconsistencies can be due to the different baseline health status of participants, environmental 
factors, tools used to assess cognition and PA, different PA programs, or statistical models. In this regard, physical 
fitness (PF) needs to be considered. PF is a measure of physical condition and well-being, and it has been reported 
that PA with an effective improvement in cardiovascular fitness has a greater effect on cognitive function than PA 
focused on strength26. We aimed to investigate the relationship between PA and PF with cognitive function and 
quality of life, independently of the impact of the adherence to an energy-restricted MedDiet, using baseline data 
from the PREDIMED-Plus trial27.
Results
Association between PF and cognitive function. Participants in the higher physical PF quartile (Q4) 
were mainly younger males (Table 1). Higher PF was associated with lower BMI (p < 0.001), longer sleeping time 
at weekends (p = 0.027), lengthier schooling time (p < 0.001) and higher education (p < 0.001). Former smokers 
were also more frequently classified in the Q4 (p < 0.001) as well as married participants (p < 0.001) and active 
workers (p < 0.001) (Table 1). Moreover, participants in the highest PF quartile had a lower prevalence of diabetes 
(p < 0.001), depression (p < 0.001) and hypertension (p = 0.002) (Table 1).
We found an association between the language domain of the MMSE test and the total MMSE score and PF 
(p = 0.024 in both cases) (Table 2). Both were higher in the upper PF quartile, although the increase in the score 
Carlos (IdISSC), Madrid, Spain. 30Primary Health Care. Servicio Navarro de Salud, Pamplona, Spain. 31Integrative 
Pharmacology and Systems Neurosciences Institut Hospital del Mar de Investigaciones Médicas Municipal 
d’Investigació Mèdica (IMIM), Barcelona, Spain. 32Primary Health Care Center San Vicente del Raspeig, Alicante, 
Spain. 33Nutrition and Genomics Laboratory, JM_USDA Human Nutrition Research Center on Aging, Tufts University, 
Boston, Massachusetts, 02111, USA. 34Department of Cardiovascular Epidemiology and Population Genetics, Centro 
Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. *email: lidia.daimiel@imdea.org
3Scientific RepoRtS |         (2020) 10:3472  | https://doi.org/10.1038/s41598-020-59458-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
was below 1%. However, when we considered the PF score as a continuous variable, we lost significance after 
complete adjustment (Supplementary Table S1). We also found a higher calculation score associated with higher 
PF, although significance was lost after complete adjustment. Similar results were found with the PF score as a 
continuous variable (Supplementary Table S1). We found that better PF was associated with a higher score in pho-
nemic (4.5%, 5.57% and 7.54% higher score for Q2, Q3 and Q4 vs. Q1, respectively) and semantic (3.24%, 5.86% 
and 6.53% higher score for Q2, Q3 and Q4 vs. Q1, respectively) verbal fluency tests (p < 0.001) (Table 2). Results 
were confirmed when we treated PF as a continuous variable (β = 0.0434 (0.0228–0.064) p = 0.001 for phonemic 
and 0.0428 (0.0203–0.0653) p = 0.003 for semantic fluency tests respectively) (Supplementary Table S1). TMT test 
time performance was also lower in higher PF quartiles. Specifically, TMT A time was 5.94%, 9.25%, and 10.32% 
lower and TMT B time was 6.14%, 10.04% and 11.05% lower in Q2, Q3 and Q4, respectively (p < 0.001 in both 
cases). When we analyzed PF as a continuous variable, we confirmed the lower TMT A time with higher PF score 
(β = −0.23 (−0.36–0.094), p = 0.0012), but we did not confirm the association between PF score and TMT B time 
(Supplementary Table S1). As sensitivity analyses, we excluded those with very high values of chair test (>2 SD, 
n = 237) as may represent implausible values/outliers and we lost the significant association with the language 
Total
Chair stand test quartile Physical Activity Level






(n = 1459) p value
N 6874 2340 1493 1631 1410 4118 1297 1459
Age (years) 64.95 ± 4.92 65.84 ± 4.78 64.98 ± 4.82 64.66 ± 5.01 63.79 ± 4.86 <0.001 65.02 ± 4.99 64.81 ± 4.77 64.88 ± 4.83 NS
Female sex (%) 48.52 59.91 48.29 44.08 34.96 <0.001 52.19 42.87 43.18 <0.001
Weight (Kg) 86.59 ± 13 87.06 ± 13.1 87.07 ± 13.29 85.89 ± 12.88 86.1 ± 12.6 0.008 87.32 ± 13.28 86.14 ± 12.85 84.9 ± 12.11 <0.001
BMI (Kg/m2) 32.56 ± 3.45 33.25 ± 3.53 32.63 ± 3.49 32.14 ± 3.32 31.84 ± 3.2 <0.001 33.02 ± 3.55 32.11 ± 3.26 31.67 ± 3.08 <0.001
Smoking status (%) <0.001
Current smoker 12.53 11.97 14 13.67 10.57 14.21 10.72 9.39 <0.001
Former smoker 43.58 37.78 43 44.27 53.05 39.92 48.57 49.49
Never smoker 43.89 50.26 43 42.06 36.38 45.87 40.71 41.12
Adherence to er-MedDiet 8.5 ± 2.67 8.44 ± 2.59 8.54 ± 2.69 8.53 ± 2.69 8.51 ± 2.75 NS 8.25 ± 2.59 8.64 ± 2.67 9.06 ± 2.8 <0.001
Marital status (%) <0.001 0.018
Married 76.51 74.15 76.16 77.87 79.22 75.33 77.1 79.3
Single 5.14 5.64 5.76 4.23 4.68 5.83 4.47 3.77
Divorced 7.93 8.38 7.3 7.3 8.58 8.31 7.71 7.06
Widowed/widower 10.43 11.84 10.78 10.61 7.52 10.54 10.72 9.87
Maximum attained educational level (%) <0.001 NS
Primary school or less 48.59 57.14 48.56 45.19 38.37 49.73 47.88 45.99
Secondary school 29.2 26.92 29.6 30.23 31.35 28.48 30.53 30.02
College or higher 22.21 15.94 21.84 24.59 30.28 21.78 21.59 23.99
Schooling time (years) 11.86 ± 8.51 11.35 ± 10.56 11.87 ± 7.98 11.97 ± 7.16 12.57 ± 6.33 <0.001 11.85 ± 9.2 11.75 ± 8.15 11.98 ± 6.55 NS
Mean sleep hours at working days 6.98 ± 1.22 6.96 ± 1.29 7.02 ± 1.2 6.95 ± 1.2 7.02 ± 1.16 NS 6.96 ± 1.25 6.96 ± 1.17 7.07 ± 1.18 0.014
Mean sleep hours at weekend 7.18 ± 1.28 7.12 ± 1.36 7.22 ± 1.24 7.16 ± 1.26 7.24 ± 1.22 0.028 7.17 ± 1.32 7.14 ± 1.23 7.22 ± 1.21 NS
Labor status (%) <0.001
Active 20.99 15.43 20.76 22.87 28.3 21.54 20.66 19.74 <0.001
Long-term inactive 23.01 28.89 22.57 21.09 15.96 24.75 21.36 19.6
Retired 55.99 55.68 56.66 56.04 55.74 53.72 57.98 60.66
Diabetes at baseline n (%) 1871 (27.22) 738 (31.54) 422 (28.27) 403 (24.71) 308 (21.84) <0.001 1175 (28.53) 344 (26.52) 352 (24.13) 0.004
Depression at baseline n (%) 1428 (20.77) 627 (26.79) 282 (18.89) 278 (17.04) 241 (17.09) <0.001 925 (22.46) 239 (18.43) 264 (18.09) <0.001
Hypertension at baseline n (%) 5750 (83.65) 1994 (85.21) 1253 (83.92) 1360 (83.38) 1143 (81.06) 0.01 3467 (84.19) 1076 (82.96) 1207 (82.73) NS
History of lung disease n (%) 23 (0.33) 7 (0.3) 9 (0.6) 2 (0.12) 5 (0.35) NS 13 (0.32) 6 (0.46) 4 (0.27) NS
History of cancer n (%) 497 (7.23) 185 (7.91) 103 (6.9) 117 (7.17) 92 (6.52) NS 310 (7.53) 90 (6.94) 97 (6.65) NS
Table 1. Baseline characteristics of the participants according to baseline fitness and PA levels. Light = light-
moderate PA activities but not every week; Moderate = moderate PA activities ≤150 min/week or vigorous 
PA activities ≤75 min/week; High = >150 min/week of moderate PA activities or >75 min/week of vigorous 
activities. NS = non significant. Q1 = 0–11 repetitions; Q2 = 12–13 repetitions; Q3 = 14–16 repetitions; 
Q4 = 17–37 repetitions. Mean ± SD for age, weight, BMI, adherence to er-MedDiet, schooling time and 
sleep hours. (%) for sex, smoking status, marital status, educational level, labor status and T2D, depression, 
hypertension, lung disease and cancer prevalence. Chair stand test quartiles and PA levels were compared with 
sex, smoking status, marital status, educational level, labor status and T2D, depression, hypertension, lung 
disease and cancer prevalence with a χ2 test and with age, weight, BMI, adherence to er-MedDiet, schooling 
time and sleep hours with ANOVA test. Significant p values in bold.
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domain but not with total MMSE test score (p = 0.006), while association with TMT A and phonemic and seman-
tic fluency tests remained significant, either analyzing PF quartiles or continuous scores (data not shown).
Association between PA levels and energy expenditure and cognitive function. Participants 
with the highest level of PA were mainly men (p < 0.001), former smokers (p < 0.001), with high adherence to 
MedDiet (p < 0.001), slept longer time in weekdays (p = 0.014) and showed lower weight (p < 0.001) and BMI 
(p < 0.001) (Table 1). Married participants were more frequently classified as high PA level, whereas single, 
divorced or widow participants were more frequently classified as light PA level (p = 0.018). Additionally, current 
workers showed a lower PA level than retired participants (p < 0.001). Finally, the prevalence of diabetes and 
depression was lower among participants with a high PA level (p = 0.017 and p = 003, respectively) (Table 1). We 
found a positive association between higher PA and higher scores in phonemic (2.39% and 5.45% for moderate 
and high PA level vs. low PA level, p < 0.001) and semantic fluency tests (0.25% and 3.88% for moderate and high 
PA level vs. low PA level, p = 0.003) under the minimally adjusted model (Table 3). However, the significance was 
lost after complete adjustment. We did not find any association between the level of PA and the score in any of the 
neurocognitive tests in the complete adjustment model (Table 3). Similarly, we found higher scores in the direct 
numeric series associated with higher PA level under the minimally adjusted model (1.73% and 3.46% for moder-
ate and high PA levels compared with low PA level, p = 0.032), but significance was lost after complete adjustment 
(Table 3). Similar results were observed when analyzing the association between scoring in neurocognitive tests 
and energy expenditure with total PA (Supplementary Table S1).
n Q1 (n = 2340) Q2 (n = 1493) Q3 (n = 1631) Q4 (n = 1410) p value
MMSE test
Temporal orientation 6669
Model 1 4.84 (4.83–4.86) 4.87 (4.85–4.9) 4.88 (4.86–4.9) 4.88 (4.86–4.9) NS
Model 2 4.89 (4.8–4.98) 4.91 (4.82–5) 4.91 (4.82–5) 4.9 (4.81–4.99) NS
Place orientation 6669
Model 1 4.96 (4.95–4.97) 4.97 (4.95–4.98) 4.96 (4.95–4.97) 4.96 (4.95–4.98) NS
Model 2 4.94 (4.89–4.99) 4.94 (4.89–5) 4.94 (4.88–4.99) 4.94 (4.89–4.99) NS
Immediate recall 6670
Model 1 2.99 (2.98–3) 2.98 (2.97–2.99) 2.99 (2.98–3) 2.99 (2.98–3) NS
Model 2 3 (2.96–3.04) 3 (2.96–3.04) 3.01 (2.97–3.05) 3 (2.96–3.04) NS
Calculation 6670
Model 1 4.43 (4.39–4.48) 4.49 (4.43–4.54) 4.54 (4.49–4.59) 4.56 (4.5–4.62) 0.038
Model 2 4.47 (4.24–4.69) 4.49 (4.27–4.71) 4.54 (4.31–4.76) 4.54 (4.32–4.77) NS
Delay recall 6670
Model 1 2.2 (2.16–2.24) 2.23 (2.19–2.28) 2.24 (2.2–2.28) 2.27 (2.22–2.32) NS
Model 2 2.22 (2.03–2.41) 2.26 (2.07–2.45) 2.27 (2.08–2.46) 2.27 (2.07–2.46) NS
Language 6650
Model 1 8.63 (8.61–8.66) 8.68 (8.65–8.71) 8.7 (8.67–8.73) 8.7 (8.66–8.73) 0.038
Model 2 8.66 (8.53–8.79) 8.7 (8.57–8.83) 8.72 (8.59–8.85) 8.73 (8.59–8.86) 0.024
Total MMSE score 6650
Model 1 28.06 (27.98–28.14) 28.23 (28.13–28.32) 28.32 (28.22–28.41) 28.35 (28.25–28.46) <0.001
Model 2 28.19 (27.79–28.58) 28.31 (27.91–28.71) 28.39 (27.99–28.79) 28.38 (27.98–28.79) 0.024
CDT score 6652
Model 1 5.87 (5.82–5.92) 5.96 (5.9–6.02) 5.93 (5.87–5.99) 6.02 (5.95–6.08) NS
Model 2 5.98 (5.71–6.24) 6.04 (5.77–6.31) 6.03 (5.76–6.29) 6.11 (5.84–6.38) NS
TMT test
Total time A 6703
Model 1 55.87 (54.72–57.02) 52.73 (51.36–54.1) 51.27 (49.96–52.58) 50.3 (48.82–51.77) <0.001
Model 2 50.48 (44.74–56.21) 47.48 (41.72–53.24) 45.81 (40.01–51.61) 45.27 (39.46–51.08) <0.001
Total time B 6784
Model 1 143.33 (140.03–146.62) 135.91 (131.98–139.84) 130.38 (126.61–134.14) 127.29 (123.06–131.53) <0.001
Model 2 131.88 (115.33–148.44) 123.78 (107.15–140.4) 118.64 (101.9–135.38) 117.3 (100.53–134.07) <0.001
COWAT test
Phonemic fluency 6723
Model 1 11.69 (11.5–11.87) 12.32 (12.1–12.55) 12.57 (12.35–12.78) 12.93 (12.69–13.17) <0.001
Model 2 12.21 (11.3–13.11) 12.76 (11.86–13.67) 12.89 (11.98–13.81) 13.13 (12.21–14.05) <0.001
Semantic fluency 6723
Model 1 15.54 (15.34–15.73) 16.05 (15.81–16.28) 16.5 (16.27–16.72) 16.62 (16.37–16.88) <0.001
Model 2 16.38 (15.39–17.37) 16.91 (15.91–17.9) 17.34 (16.34–18.34) 17.45 (16.45–18.46) <0.001
DS test
Direct numeric series 
score
5345 Model 1 8.59 (8.47–8.7) 8.83 (8.7–8.97) 8.8 (8.67–8.93) 8.87 (8.72–9.01) NS
Model 2 8.56 (7.95–9.17) 8.68 (8.07–9.3) 8.54 (7.92–9.16) 8.51 (7.89–9.13) NS
Direct span
2213 Model 1 5.45 (5.33–5.56) 5.48 (5.34–5.62) 5.5 (5.37–5.63) 5.62 (5.46–5.77) NS
Model 2 5.58 (5.12–6.05) 5.62 (5.16–6.08) 5.58 (5.11–6.05) 5.68 (5.2–6.15) NS
Inverse numeric series 
score
5347 Model 1 4.96 (4.86–5.07) 5.15 (5.03–5.27) 5.11 (5–5.23) 5.19 (5.06–5.32) NS
Model 2 4.83 (4.3–5.36) 4.88 (4.34–5.42) 4.74 (4.2–5.28) 4.74 (4.2–5.28) NS
Inverse Span
2200 Model 1 3.6 (3.49–3.7) 3.73 (3.61–3.86) 3.77 (3.65–3.89) 3.81 (3.67–3.95) NS
Model 2 3.69 (3.28–4.09) 3.81 (3.41–4.21) 3.78 (3.37–4.19) 3.83 (3.42–4.24) NS
Table 2. Comparison of the cognitive assessment variables of the participants according to their physical fitness 
(quartiles). COWAT = Controlled Oral Word Association Test; DS = Digit Span test; MMSE = Mini-mental 
State Examination test; TMT = Trail Making Test. NS = non significant. Q1 (0–11 repetitions); Q2 (12–13 
repetitions); Q3 (14–16 repetitions); Q4 (17–37 repetitions). Mean ± (95% confidence interval). Model 1: 
ANCOVA adjusted for age, sex and recruitment center. Model 2: ANCOVA adjusted for age, sex, recruitment 
center, smoking status, adherence to er-MedDiet, BMI, civil status, educational level, sleep hours, working status, 
TV hours and prevalence of type 2 diabetes, depression, hypertension and cancer. Significant p values in bold.
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Association between both, PF and PA and health-related quality of life. Higher levels of PA and 
higher energy expenditure with total PA were associated with higher scores in all domains of the SF36-HRQL 
questionnaire (Table 4 and Supplementary Table S2). Accordingly, individuals in the upper quartile of PF or with 
higher Chair Stand repetitions showed higher scores in all domains of the HRQL-SF36 questionnaire, including 
the aggregated physical and mental health domains (Table 5 and Supplementary Table S2). We repeated the analysis 
excluding those with very high values of chair test (>2 SD, n = 237) and results did not change (data not shown).
Discussion
Our study showed that PF was positively associated with a better performance in the TMT, measuring executive 
function, and the COWAT, measuring language ability and executive control. These results are in accordance 
with those reported by Alosco et al. in 200 adult patients of heart failure using a similar battery of cognitive and 
PF tests28. The authors suggested that the negative effect of obesity on cognitive function was likely a result of 
the combination of clinical factors (obesity, diabetes, and hypertension) and PF28. Because we included BMI, 
diabetes, and hypertension as adjusting co-variables, our results suggest that PF influences cognitive function 
independently of these other factors.
We did not find any association between the level of PA and cognitive function. The association between PA 
and cognitive function is still controversial. Some previous reports have suggested a positive association. For 
n Low (n = 4118) Moderate (n = 1297) High (n = 1459) p for trend
MMSE test
Temporal orientation 6669
Model 1 4.86 (4.85–4.87) 4.88 (4.86–4.91) 4.87 (4.85–4.9) NS
Model 2 4.9 (4.81–4.99) 4.92 (4.83–5.01) 4.88 (4.79–4.98) NS
Place orientation 6669
Model 1 4.96 (4.95–4.97) 4.96 (4.94–4.97) 4.96 (4.95–4.98) NS
Model 2 4.94 (4.89–4.99) 4.94 (4.89–4.99) 4.93 (4.88–4.98) NS
Immediate recall 6670
Model 1 2.99 (2.98–2.99) 2.98 (2.97–2.99) 2.99 (2.98–3) NS
Model 2 3 (2.96–3.04) 3 (2.96–3.04) 3 (2.96–3.04) NS
Calculation 6670
Model 1 4.49 (4.45–4.52) 4.5 (4.44–4.56) 4.53 (4.47–4.59) NS
Model 2 4.51 (4.28–4.73) 4.49 (4.26–4.71) 4.49 (4.26–4.72) NS
Delayed recall 6670
Model 1 2.23 (2.2–2.26) 2.22 (2.18–2.27) 2.23 (2.18–2.28) NS
Model 2 2.25 (2.06–2.44) 2.25 (2.05–2.44) 2.24 (2.05–2.44) NS
Language 6650
Model 1 8.67 (8.65–8.69) 8.66 (8.62–8.69) 8.68 (8.64–8.71) NS
Model 2 8.7 (8.57–8.83) 8.68 (8.55–8.81) 8.7 (8.56–8.83) NS
Total MMSE score 6650
Model 1 28.2 (28.14–28.26) 28.21 (28.11–28.32) 28.27 (28.16–28.37) NS
Model 2 28.31 (27.92–28.7) 28.28 (27.88–28.68) 28.25 (27.85–28.65) NS
CDT score 6652
Model 1 5.95 (5.91–5.99) 5.93 (5.86–6) 5.9 (5.83–5.97) NS
Model 2 6.03 (5.77–6.3) 6.03 (5.76–6.3) 6.01 (5.74–6.28) NS
TMT test
Total time A 6703
Model 1 53.5 (52.65–54.35) 52.66 (51.19–54.13) 51.41 (49.91–52.92) NS
Model 2 48.28 (42.58–53.98) 47.97 (42.16–53.79) 45.82 (39.99–51.65) NS
Total time B 6784
Model 1 136.59 (134.15–139.03) 133.04 (128.81–137.26) 133.48 (129.16–137.81) NS
Model 2 123.82 (107.36–140.28) 126.1 (109.31–142.89) 125.46 (108.63–142.3) NS
COWAT test
Phonetic fluency 6723
Model 1 12.11 (11.97–12.25) 12.4 (12.16–12.64) 12.77 (12.53–13.02) <0.001
Model 2 12.6 (11.7–13.5) 12.67 (11.75–13.59) 12.89 (11.97–13.81) NS
Semantic fluency 6723
Model 1 15.97 (15.83–16.12) 16.01 (15.75–16.26) 16.59 (16.33–16.85) 0.003
Model 2 16.88 (15.9–17.87) 16.69 (15.69–17.7) 17.21 (16.21–18.22) NS
DS test
Direct numeric series 
score 5345
Model 1 8.67 (8.59–8.75) 8.82 (8.67–8.97) 8.97 (8.82–9.12) 0.032
Model 2 8.58 (7.98–9.19) 8.55 (7.93–9.17) 8.55 (7.93–9.17) NS
Direct span 2213
Model 1 5.47 (5.36–5.57) 5.51 (5.38–5.65) 5.54 (5.4–5.68) NS
Model 2 5.61 (5.15–6.07) 5.6 (5.13–6.06) 5.64 (5.18–6.11) NS
Inverse numeric series 
score 5347
Model 1 5.05 (4.97–5.12) 5.14 (5–5.27) 5.18 (5.05–5.32) NS
Model 2 4.82 (4.29–5.35) 4.82 (4.28–5.36) 4.72 (4.18–5.26) NS
Inverse Span 2200
Model 1 3.68 (3.59–3.78) 3.67 (3.55–3.79) 3.78 (3.65–3.91) NS
Model 2 3.76 (3.36–4.16) 3.74 (3.33–4.14) 3.85 (3.44–4.26) NS
Table 3. Comparison of the cognitive assessment variables of the participants according to their PA level. 
COWAT = Controlled Oral Word Association Test; DS = Digit Span test; MMSE = Mini-mental State 
Examination test; TMT = Trail Making Test. NS = non significant. Light = light-moderate PA activities but 
not every week; Moderate = moderate PA activities ≤150 min/week or vigorous PA activities ≤75 min/week; 
High = >150 min/week of moderate PA activities or >75 min/week of vigorous activities. Mean ± (95% 
confidence interval). Model 1: ANCOVA adjusted for age, sex and recruitment center. Model 2: ANCOVA 
adjusted for age, sex, recruitment center, smoking status, adherence to er-MedDiet, BMI, civil status, 
educational level, sleep hours, working status, TV hours and prevalence of type 2 diabetes, depression, 
hypertension and cancer. Significant p values in bold.
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n Low (n = 4118) Moderate (n = 1297) High (n = 1459) p value
General health 6490
Model 1 58.58 (58.01–59.16) 62.9 (61.91–63.9) 65.63 (64.61–66.65) <0.001
Model 2 50.57 (46.85–54.28) 53.67 (49.89–57.46) 55.33 (51.53–59.13) <0.001
Physical function 6363
Model 1 72.81 (72.22–73.4) 79.35 (78.34–80.37) 83.07 (82.03–84.1) <0.001
Model 2 67.19 (63.29–71.1) 72.18 (68.2–76.17) 74.51 (70.52–78.5) <0.001
Physical role 6636
Model 1 72.15 (71.04–73.27) 78.37 (76.44–80.31) 81.94 (79.96–83.92) <0.001
Model 2 55.88 (48.52–63.24) 60.54 (53.03–68.05) 63.05 (55.52–70.58) <0.001
Emotional role 6678
Model 1 85 (84.03–85.96) 89.17 (87.51–90.83) 89.48 (87.78–91.18) <0.001
Model 2 77.94 (71.34–84.53) 80.75 (74.02–87.48) 80.58 (73.83–87.33) 0.002
Vitality 6435
Model 1 60.32 (59.66–60.99) 65.85 (64.7–67) 69.18 (68–70.36) <0.001
Model 2 56.77 (52.47–61.07) 60.7 (56.31–65.08) 63.14 (58.74–67.54) <0.001
Mental health 6269
Model 1 72.84 (72.22–73.46) 75.7 (74.62–76.78) 77.31 (76.22–78.41) <0.001
Model 2 67.05 (63.17–70.94) 68.71 (64.74–72.68) 69.95 (65.97–73.93) <0.001
Social function 6591
Model 1 83.44 (82.77–84.1) 88.22 (87.07–89.37) 89.71 (88.53–90.88) <0.001
Model 2 75.9 (71.46–80.33) 79.48 (74.96–84) 80.38 (75.84–84.92) <0.001
Body pain 6719
Model 1 64.44 (63.63–65.25) 69.1 (67.7–70.5) 73.81 (72.38–75.25) <0.001





Model 1 44.17 (43.87–44.47) 46.21 (45.7–46.73) 48.09 (47.57–48.61) <0.001
Model 2 40.66 (38.67–42.66) 42.13 (40.09–44.17) 43.5 (41.45–45.54) <0.001
Aggregated Mental 
Dimensions 5446
Model 1 50.5 (50.14–50.86) 51.76 (51.13–52.39) 51.96 (51.32–52.59) <0.001
Model 2 48.25 (45.83–50.67) 49.05 (46.58–51.52) 49.12 (46.64–51.59) 0.011
Table 4. Adjusted means for HRQL dimensions according to baseline PA levels. Light = light-moderate PA 
activities but not every week; Moderate = moderate PA activities ≤150 min/week or vigorous PA activities 
≤75 min/week; High = >150 min/week of moderate PA activities or >75 min/week of vigorous activities. 
Mean ± (95% confidence interval). Model 1: ANCOVA adjusted for age, sex and recruitment center. Model 
2: ANCOVA adjusted for age, sex, recruitment center, smoking status, adherence to er-MD, BMI, civil status, 
educational level, sleep hours, working status, TV hours and prevalence of type 2 diabetes, depression, 
hypertension and cancer. Significant p values in bold.
n Q1 (n = 2340) Q2 (n = 1493) Q3 (n = 1631) Q4 (n = 1410) p value
General health 6490
Model 1 56.53 (55.75–57.3) 61.42 (60.49–62.35) 63.13 (62.24–64.02) 64.29 (63.29–65.28) <0.001
Model 2 49.15 (45.4–52.89) 52.94 (49.18–56.7) 53.7 (49.91–57.49) 54.08 (50.29–57.87) <0.001
Physical function 6363
Model 1 69.04 (68.25–69.83) 76.87 (75.94–77.81) 79.67 (78.76–80.57) 82.3 (81.3–83.3) <0.001
Model 2 64.18 (60.27–68.09) 70.85 (66.93–74.77) 72.42 (68.47–76.36) 73.61 (69.65–77.56) <0.001
Physical role 6636
Model 1 66.9 (65.39–68.4) 76.55 (74.76–78.34) 80.23 (78.51–81.94) 81.6 (79.68–83.52) <0.001
Model 2 51.56 (44.17–58.94) 59.87 (52.46–67.28) 62.53 (55.06–69.99) 62.79 (55.32–70.27) <0.001
Emotional role 6678
Model 1 83.04 (81.74–84.35) 88.2 (86.64–89.76) 88.13 (86.64–89.62) 89.23 (87.57–90.9) <0.001
Model 2 76.01 (69.37–82.65) 80.23 (73.55–86.91) 80.2 (73.49–86.92) 81.17 (74.45–87.9) <0.001
Vitality 6435
Model 1 57.62 (56.72–58.51) 63.52 (62.44–64.59) 66.02 (65–67.05) 68.12 (66.98–69.27) <0.001
Model 2 54.67 (50.34–58.99) 59.28 (54.94–63.62) 61.26 (56.89–65.64) 62.48 (58.09–66.86) <0.001
Mental health 6269
Model 1 70.86 (70.03–71.69) 75.35 (74.35–76.34) 75.88 (74.93–76.84) 76.77 (75.7–77.84) <0.001
Model 2 65.22 (61.31–69.13) 68.73 (64.81–72.66) 69.37 (65.41–73.32) 69.96 (66–73.93) <0.001
Social function 6591
Model 1 81.01 (80.11–81.9) 86.88 (85.81–87.96) 87.93 (86.9–88.95) 88.86 (87.71–90) <0.001
Model 2 73.73 (69.27–78.19) 78.8 (74.32–83.28) 79.42 (74.92–83.93) 79.82 (75.3–84.33) <0.001
Body pain 6719
Model 1 60.02 (58.94–61.11) 68.13 (66.83–69.42) 71.11 (69.86–72.35) 73.1 (71.7–74.49) <0.001





Model 1 42.47 (42.07–42.87) 45.69 (45.22–46.17) 46.85 (46.39–47.3) 47.81 (47.31–48.31) <0.001





Model 1 49.91 (49.42–50.4) 51.55 (50.96–52.14) 51.62 (51.05–52.18) 51.61 (50.99–52.23) <0.001
Model 2 47.59 (45.15–50.02) 48.88 (46.43–51.33) 49.15 (46.69–51.61) 49.18 (46.72–51.64) <0.001
Table 5. Adjusted means for HRQL dimensions according to the baseline level of PF (quartiles). Q1 (0–11 
repetitions); Q2 (12–13 repetitions); Q3 (14–16 repetitions); Q4 (17–37 repetitions). Mean ± (95% confidence 
interval). Model 1: ANCOVA adjusted for age, sex and recruitment center. Model 2. ANCOVA adjusted for age, 
sex, recruitment center, smoking status, adherence to er-MD, BMI, civil status, educational level, sleep hours, 
working status, TV hours and prevalence of type 2 diabetes, depression, hypertension and cancer. Significant p 
values in bold.
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instance, a study conducted in 2,315 cognitively healthy elder participants from CFAS-Wales study showed that 
PA was positively associated with cognitive function measured by the Cambridge Cognitive Examination battery 
of neuropsychological tests29 and a larger observational study carried out in 93,082 respondents ≥45 years old 
from 21 US states reported that people with self-reported cognitive decline were more frequently inactive than 
those without this subjective cognitive decline status30. Moreover, the study conducted by Xu et al. in 27,651 par-
ticipants (50–85 years old) showed a dose-response relationship between PA and cognitive function14. Other pop-
ulation studies and meta-analyses support an association between PA and cognitive function20,22,31. Conversely, 
Kooistra et al. did not find any association between PA and cognitive performance or cognitive decline in a 
baseline analysis of 1,232 participants of the SMART-RM study16. These inconsistencies could be related to dif-
ferences in populations and tools used to measure cognitive function and PA. The intensity of the PA could also 
be a determinant factor. The OSHPE study found that moderate activity, but not light activity, was associated 
with hippocampal volume but not with memory15 and a recent systematic review concluded that moderate and 
vigorous leisure-time PA was associated with benefits in different cognitive domains in older adults17. Therefore, 
it is possible that an association between PA and cognitive function was significant only in individuals at a high 
PA level. Indeed, our results show a trend towards a better scoring in TMT and COWAT test in participants cat-
egorized as high-level PA.
The discordant results could also be attributed to the type of PA, aerobic, or resistance/strength exercises, with 
aerobic exercises likely having a greater effect. Protocols for each type of exercise are different in intensity and 
length and produce different physical adaptations, with aerobic exercise having a greater impact on %VO2max 
and energy expenditure32–34. We found that, although higher PA and PF levels were both associated with bet-
ter self-reported quality of life, only PF was associated with cognitive function. This differential effect could be 
attributed to a different impact of aerobic vs. anaerobic exercise on cognitive function. Aerobic fitness has been 
positively correlated with better high-interference memory in older adults18, and aerobic exercises have been 
associated with better improvement in the score of neuropsychological tests in comparison with anaerobic exer-
cise35. Aerobic exercise in the elderly has also been associated with better performance on tasks requiring execu-
tive control in comparison with anaerobic exercises36. Other reports also showed a specific association between 
aerobic exercise, but not anaerobic exercise, and executive control37,38.
Moreover, a meta-analysis published in 2003 found robust, but specific, benefits of aerobic fitness on cogni-
tive function19. Another meta-analysis including 29 randomized interventional trials involving aerobic exercise 
training (n = 2049) found a moderate but consistent improvement in attention and processing speed, executive 
function and memory associated with aerobic exercise. However, it failed to find any association with working 
memory21. These studies strongly support the hypothesis that aerobic exercise, but not anaerobic one, has a spe-
cific impact on executive function. We did not discriminate between aerobic and anaerobic exercise, neither 
measured cardiorespiratory fitness; however, we found a significant association between TMT and COWAT tests 
and PF. TMT test measures the speed of information processing and the COWAT test measures verbal memory, 
attention, and inhibition. Together, they define the individual condition regarding executive function and cogni-
tive control. Therefore, our results strongly suggest that good PF, achieved through an aerobic exercise program, 
could be a significant predictor of executive function in the elderly. The mechanisms behind these associations 
could be the increase in the hippocampal volume associated with aerobic fitness39. In this regard, a randomized 
clinical trial conducted in 120 adults without dementia showed an increase in the volume of the left and right 
hippocampus in the aerobic exercise group and a decrease in the stretching control group after one year34.
Interestingly, authors showed a selective impact of aerobic exercise on the volume of the anterior hippocam-
pus, involved in spatial memory and submitted to age-related atrophy34. However, a Cochrane systematic review 
showed no effect of aerobic exercise, even if the intervention leads to an improvement in cardiorespiratory fitness, 
on cognitive domains23. More extensive interventional studies are, therefore, needed to clarify the impact of aer-
obic exercise leading to an improved PF on cognitive function.
We also found that PF was associated with a better quality of life, with positive associations in all domains, 
including the aggregated ones. PF has been reported to account for up to 22.5% of the variability in the quality 
of life scoring of obese individuals with binge eating disorder40, and cardiorespiratory fitness has been suggested 
to be a good predictor of physical and mental quality of life in individuals with bipolar disorder41. Our results 
reinforce the hypothesis that PF is associated with a better cognitive function and quality of life and encourage the 
development of PA programs addressed to increase PF in the late adulthood to prevent morbidity in the elderly. 
Although PA levels seemed not to be associated with cognitive function, they were associated with a higher score 
in all domains of the quality of life questionnaire. These results are consistent with the previously reported asso-
ciation between PA and quality of life in the elderly42,43.
In conclusion, our results showed that PF, but not PA level, was associated with cognitive function, specifically 
with those domains related to language ability, attention, and processing speed. Undoubtedly, PA, specifically aer-
obic exercises, contribute to PF and thus PA could be associated with cognitive function through an improvement 
in PF. Our results highlight the importance of maintaining a good physical condition to retain cognitive function. 
In this regard, the primary aim of PA programs addressed to maintain cognitive health should be the improve-
ment of PF, and the type of exercise should be considered when designing PA programs.
This study has some limitations. First, this is an observational cross-sectional study that does not allow to infer 
causality. Second, this is an elderly population with obesity and metabolic syndrome with an average low level of 
PA and without cognitive impairment and this could be masking a significant relationship between PA and cogni-
tive function. However, this population is representative of a high cardiovascualr disease (CVD) risk elderly pop-
ulation in a medium-high income Western country and this study has been carried out with a large sample and 
with a stringent adjustment for confounding factors. Third, HRQL and PA activities are self-reported; thus, we 
cannot rule out the overestimation or underestimation of those variables. Although we have adjusted for potential 
confounding factors (age, gender, recruitment center, adherence to an er-MedDiet, BMI, civil status, educational 
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level, sleep hours, working status, TV hours, prevalence of T2DM, depression, hypertension and cancer) our 
population is heterogeneous, especially regarding sociodemographic parameters like civil status, education level 
and working status. Thus, we cannot rule out the possibility that this heterogeneity produced a moderation or 
exacerbation of the observed association between PF and cognitive function.
Finally, we should bear in mind that past experiences or the accumulation of other factors, not considered 
within this analysis, may also have an impact on cognitive function in the elderly.
Methods
Study design and participants. We used baseline data of the PREDIMED-Plus trial, a 6-year multicenter, 
randomized, parallel-group clinical trial conducted in Spain for primary prevention of CVD through lifestyle 
modification. The cohort and protocol, including sample size calculation and recruitment flowchart, have been 
described27, and the protocol can be found at the PREDIMED-Plus website44. This trial was retrospectively reg-
istered at the International Standard Randomized Controlled Trial (ISRCTN89898870, https://www.isrctn.com/
ISRCTN89898870?q=ISRCTN89898870&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&
searchType=basic-search) on 07/24/2014. Participants were recruited by primary care health doctors and nurses 
associated with study centers who assessed the inclusion/exclusion criteria. Eligible participants were communi-
ty-dwelling adults (55–75 years men and 60–75 years women) with overweight/obesity (27 ≤ BMI ≥ 40 Kg/m2) 
who met at least three criteria of metabolic syndrome (according to the International Diabetes Federation and the 
American Heart Association)45 without cardiovascular and neurodegenerative disease at baseline. We included 
baseline data from 6874 participants recruited in 23 Spanish study centers from October 2013 to December 2016. 
Data include cognitive function, PA, quality of life, anthropometrical and biochemical measures, PF conditions, 
history of cancer or lung, disease sociodemographic parameters, and depression status27.
The study protocol and procedures were approved according to the ethical standards of the Declaration of 
Helsinki by the Institutional Review Boards (IRBs) of all the participating institutions: CEI Provincial de Málaga, 
CEI de los Hospitales Universitarios Virgen Macarena y Virgen del Rocío, CEI de la Universidad de Navarra, 
CEI de las Illes Balears, CEIC del Hospital Clínic de Barcelona, CEIC del Parc de Salut Mar, CEIC del Hospital 
Universitari Sant Joan de Reus, CEI del Hospital Universitario San Cecilio, CEIC de la Fundación Jiménez Díaz, 
CEIC Euskadi, CEI en Humanos de la Universidad de Valencia, CEIC del Hospital Universitario de Gran Canaria 
Doctor Negrín, CEIC del Hospital Universitario de Bellvitge, CEIC de IMDEA Alimentación, CEIC del Hospital 
Clínico San Carlos, CEI Provincial de Málaga, CCEIBA de la Investigación Biomédica de Andalucía, CEIC del 
Hospital General Universitario de Elche, Comité de Ética del Hospital Universitario Reina Sofía and CEIC de 
León. All participants provided informed written consent.
Dietary and anthropometrical measures. Adherence to an er-MedDiet diet was measured through a 
17-item questionnaire in which an adequate consumption of typical traditional Mediterranean foods adds add 
one point, and low consumption of foods that are not characteristic of the traditional Mediterranean diet also 
adds one point. This questionnaire has been specially developed for the PREDIMED-Plus trial11 and was applied 
by a trained nutritionist in a face-to-face interview. Weight and height were measured with light clothing and 
no shoes, with calibrated scales and a wall-mounted stadiometer, respectively. BMI was calculated as weight in 
kilograms divided by the square of height in meters.
Physical activity and fitness. PF was assessed using the 30 seconds Chair Stand test designed to test the 
functional fitness of senior population46. Participants were classified according to quartiles of test scoring: Q1 
(0–11 repetitions), Q2 (12–13 repetitions), Q3 (14–16 repetitions) and Q4 (17–37 repetitions).
PA was assessed using the validated REGICOR questionnaire and the Rapid Assessment of Physical Activity 
Questionnaire (RAPA)47. REGICOR questionnaire provides information about PA intensity according to energy 
expenditure (MET/min/week) distinguishing light (<4 MET), moderate (4–5.5 MET) and vigorous (≥6 MET) 
PA and recording information about the PA at work and in everyday life and about sedentary behaviors42. 
Frequency and intensity of PA are quantified by requesting participants to provide information about the fre-
quency (days per month) and the intensity (minutes per session) of physical activities like light walking, brisk 
walking, gardening, trail/hiking, climbing stairs, other indoor or outdoor sports activities. RAPA questionnaire 
allows an easy identification of PA level as low (light-moderate PA activities but not every week), moderate (mod-
erate PA activities less than 150 minutes per week or vigorous PA activities less than 75 minutes per week) or high 
(more than 150 minutes per week of moderate PA activities or more than 75 minutes per week of vigorous activi-
ties). Trained interviewers administered PA questionnaires in individual face-to-face sessions.
Neuropsychological assessment. Executive function was measured with the Trail-making Test (TMT) A 
and B3,48. TMT-A provides information about cognitive processing skills (psychomotor speed, processing speed, 
and visuospatial skills), whereas TMT-B provides information about executive functioning49. In task A, partici-
pants are requested to connect circled numbers 1–25 in the correct order. In task B, numbers and letters have to 
be alternatively connected following an ascending order in each case (1-A-2-B-3-C-…).
Semantic and phonemic verbal ability and executive control were measured with the Controlled Oral Word 
Association Test (COWAT)3,50. Semantic fluency is evaluated by requesting participants to mention as many 
animals as possible in 1 minute. Phonemic fluency is evaluated by requesting participants to say as many words 
starting with “P” as they can in 1 minute50.
Short-term memory and attention and working memory were measured by the forward and backward Digit 
Span (DS) test of the Wechsler Adult Intelligence Scale-III battery3,51, respectively. In the DS-Forward recall, partici-
pants are requested to repeat a series of random single digits in the same order they heard them. In the DS-Backward 
recall they are requested to repeat another series of a random single digit in the inverse order they heard them.
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Cognitive impairment was assessed with the Mini-mental State Examination test (MMSE) and the 
Clock-Drawing test (CDT)52–54. The MMSE test is a 30-point questionnaire that examines domains like time and 
spatial orientation, immediate and deferred recall, attention, calculation, and language. A score is calculated for 
each domain, and all are added to obtain a total MMSE score. A threshold of 24 is defined to identify cognitive 
impairment. The CDT is useful to examine visuospatial functioning and memory. Participants are required to draw 
a clock with a specific time, and a numeric score of 0 or 1 is given depending if they correctly or incorrectly draw 
the numbers, minute and seconds clock hands and the requested time49. All scores are sum to get a total CDT score.
All cognitive tests were applied by nutritionists who had been previously trained.
Health-related quality of life (HRQL). We used an adapted version of previously published 36-items 
HRQL questionnaire (SF36-HRQL)55, which was validated for the Spanish population and extensively used to 
measure the subjective perception of health and capability or physical limitations to manage with daily tasks56, as 
described before11,57.
Statistical analyses. Baseline characteristics of the participants were described as means ± SD for quanti-
tative variables and as proportions for qualitative variables. Chair Stand test scores and MET/Min/week of total 
PA were used to quantitatively measure PF and PA, respectively, and were analyzed as continuous variables. 
Additionally, participants were classified according to the quartile of PF measured by the Chair Stand test.: Q1 
(0–11 repetitions), Q2 (12–13 repetitions), Q3 (14–16 repetitions) and Q4 (17–37 repetitions). PA activity level 
was also analyzed as a categorical variable: low, moderately, and highly active. The participant’s categorization has 
been described above.
Characteristics of the participants were compared among PF quartiles and PA levels with the χ2 test for cate-
gorical variables and ANOVA for continuous variables.
The score for each domain of the SF36-HRQL tests as well as for the aggregated dimensions was treated as a 
continuous variable and compared with PA and PF with ANCOVA. Neurocognitive scores were also treated as 
continuous variables and compared with PA levels and PF with ANCOVA.
SF36-HRQL and neurocognitive scores (independent variables) were analyzed for their association with Chair 
Stand test score and MET/min/week energy expenditure as continuous variables (dependent variables) with a 
linear regression model.
Two adjustment models were applied. Model 1 adjustment (minimal adjustment) included age, gender, and 
recruitment center as cofactors. Model 2 adjustment (complete adjustment) included, additionally, smoking sta-
tus (current, never or former smoker), adherence to er-MedDiet11, BMI, civil status (married, single, divorced or 
widow), educational level (primary, secondary or college), sleep hours, working status (active, long-term inac-
tive or retired), TV hours, prevalence of T2DM3, depression, hypertension and cancer. We included data from 
6874 participants. Missing values for predictive and descriptive variables were imputed using Predictive Mean 
Matching. The specific sample size for outcome variables is detailed in corresponding tables. The percentage of 
missing values range from 0.029 to 9%, except for the DS test and the aggregated physical and mental dimen-
sions of the SF36-HRQL test, for whose percentage of missing values ranged from 20.99% to 67.99%. To prevent 
from type-I error inflation, a multiple testing correction with the Holm’s method was applied58. Holm’s method 
is a sequential hypothesis rejection test that controls the family-wise error rate like Bonferroni’s one but with 
much increased power. As sensitivity analyses, we excluded participants with >2 SD values of the Chair Stand 
Test (n = 237) as may represent implausible values/outliers and repeated ANCOVA analyses. We considered the 
two-tailed significant level of 0.05 as a threshold for statistical significance. All analyses were conducted with data 
from database version 201903131142_PREDIMEDplus_2019-03-12 and with R.
Data availability
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of the PREDIMED-Plus Steering Committee for deliberation.
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